AbbVie (NYSE:ABBV) is scheduled to announce Q3 earnings results on Friday, November 1st, before market open.
The consensus EPS Estimate is $2.30 (+7.5% Y/Y) and the consensus Revenue Estimate is $8.37B (+1.6% Y/Y).
Over the last 2 years, abbv has beaten EPS estimates 88% of the time and has beaten revenue estimates 75% of the time.
Over the last 3 months, EPS estimates have seen 8 upward revisions and 0 downward. Revenue estimates have seen 6 upward revisions and 2 downward.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.